Bisphenol A (3-Chloro-2-hydroxypropyl)(2,3-dihydroxypropyl)ether, 98%

Name: Bisphenol A (3-Chloro-2-hydroxypropyl)(2,3-dihydroxypropyl)ether, 98% | 227947-06-0
Brand: J&K Chemical
SKU: JK618632_5_MG
Price: 108.3 USD
Availability: OutOfStock

Cat. No JK618632_5_MG

Vendor: J&K Chemical

Product Information

Product Name

Bisphenol A (3-Chloro-2-hydroxypropyl)(2,3-dihydroxypropyl)ether, 98%

Brand Name

J&K

Product Number

618632

CAS

227947-06-0

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

4166922

IUPAC Name

3-4-2-4-(3-chloro-2-hydroxypropoxy)phenylpropan-2-ylphenoxypropane-1,2-diol

InChI Key

HDTYUHNZRYZEEB-UHFFFAOYSA-N

SMILES

CC(C)(C1=CC=C(C=C1)OCC(CO)O)C2=CC=C(C=C2)OCC(CCl)O

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Synthesis and Evaluation of Small Molecule Inhibitors of the Androgen Receptor N-Terminal Domain

Publication Name: ACS Medicinal Chemistry Letters

Publication Date: 2023-11-17

DOI: 10.1021/acsmedchemlett.3c00426

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Publication Name: Science Translational Medicine

Publication Date: 2023-06-21

DOI: 10.1126/scitranslmed.add7872

Therapeutic Strategies to Target the Androgen Receptor

Publication Name: Journal of Medicinal Chemistry

Publication Date: 2022-07-05

DOI: 10.1021/acs.jmedchem.2c00716

A critical update on the strategies towards modulators targeting androgen receptors

Publication Name: Bioorganic & Medicinal Chemistry

Publication Date: 2020-07-01

DOI: 10.1016/j.bmc.2020.115554

High-Throughput Screening to Identify Inhibitors of the Type I Interferon–Major Histocompatibility Complex Class I Pathway in Skeletal Muscle

Publication Name: ACS Chemical Biology

Publication Date: 2020-05-27

DOI: 10.1021/acschembio.0c00343

Bisphenol A (3-Chloro-2-hydroxypropyl)(2,3-dihydroxypropyl)ether, 98%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Synthesis and Evaluation of Small Molecule Inhibitors of the Androgen Receptor N-Terminal Domain

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Therapeutic Strategies to Target the Androgen Receptor

A critical update on the strategies towards modulators targeting androgen receptors

High-Throughput Screening to Identify Inhibitors of the Type I Interferon–Major Histocompatibility Complex Class I Pathway in Skeletal Muscle